Common and Rare Ocular Side-effects of the Dexamethasone Implant

Janelle M. Fassbender Adeniran, Denis Jusufbegovic, Shlomit Schaal

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.

Original languageEnglish (US)
Pages (from-to)834-840
Number of pages7
JournalOcular Immunology and Inflammation
Volume25
Issue number6
DOIs
StatePublished - Nov 2 2017
Externally publishedYes

Fingerprint

Dexamethasone
National Library of Medicine (U.S.)
Retinal Vein Occlusion
Ocular Hypertension
Macular Edema
Uveitis
National Institutes of Health (U.S.)
Traction
PubMed
Cataract
Randomized Controlled Trials
Infection
Pharmaceutical Preparations

Keywords

  • Cystoid macular edema
  • dexamethasone
  • Ozurdex
  • retinal vein occlusion
  • side-effects
  • uveitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Cite this

Common and Rare Ocular Side-effects of the Dexamethasone Implant. / Fassbender Adeniran, Janelle M.; Jusufbegovic, Denis; Schaal, Shlomit.

In: Ocular Immunology and Inflammation, Vol. 25, No. 6, 02.11.2017, p. 834-840.

Research output: Contribution to journalReview article

Fassbender Adeniran, Janelle M. ; Jusufbegovic, Denis ; Schaal, Shlomit. / Common and Rare Ocular Side-effects of the Dexamethasone Implant. In: Ocular Immunology and Inflammation. 2017 ; Vol. 25, No. 6. pp. 834-840.
@article{16a5bd8ce3dc4e7199ce783c84a452a7,
title = "Common and Rare Ocular Side-effects of the Dexamethasone Implant",
abstract = "Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.",
keywords = "Cystoid macular edema, dexamethasone, Ozurdex, retinal vein occlusion, side-effects, uveitis",
author = "{Fassbender Adeniran}, {Janelle M.} and Denis Jusufbegovic and Shlomit Schaal",
year = "2017",
month = "11",
day = "2",
doi = "10.1080/09273948.2016.1184284",
language = "English (US)",
volume = "25",
pages = "834--840",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Common and Rare Ocular Side-effects of the Dexamethasone Implant

AU - Fassbender Adeniran, Janelle M.

AU - Jusufbegovic, Denis

AU - Schaal, Shlomit

PY - 2017/11/2

Y1 - 2017/11/2

N2 - Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.

AB - Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.

KW - Cystoid macular edema

KW - dexamethasone

KW - Ozurdex

KW - retinal vein occlusion

KW - side-effects

KW - uveitis

UR - http://www.scopus.com/inward/record.url?scp=84979057689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979057689&partnerID=8YFLogxK

U2 - 10.1080/09273948.2016.1184284

DO - 10.1080/09273948.2016.1184284

M3 - Review article

C2 - 27379861

AN - SCOPUS:84979057689

VL - 25

SP - 834

EP - 840

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 6

ER -